Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 600 people, planned
- Started
- 6 Jul 2018
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Meditation
- Record updated
- 8 October 2026
Who can take part
- Age
- 8 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (14)Hide the full registry criteria
Who can take part
- Children aged 8 years of age through adulthood
- Diagnosis of pectus excavatum or adolescent idiopathic scoliosis
- Scheduled for endoscopic pectus excavatum repair or spine fusion
Who cannot take part
- Major surgery requiring opioids in the last 5 years
- Taking no more than two concomitant medications known to induce or inhibit CYP2D6 activity, including paroxetine, fluoxetine, cimetidine, and duloxetine
- History of or active renal or liver disease
- Cardiac conditions including, but not limited to, cyanotic heart disease, hypoplastic left ventricle, arrhythmia, hypertension with ongoing treatment, Kawasaki disease, or cardiomyopathies. Participants with asymptomatic valvular lesions or defects may be included
- History of seizures currently treated on medication (participants off medication and seizure free for greater than one year may be included)
- Needing postoperative ventilation or intraoperative cardiac bypass standby
- Severe respiratory problems (such as obstructive sleep apnea, cystic fibrosis, pulmonary fibrosis, or pneumonia within the last month)
- BMI >35
- Pregnant or breastfeeding females
- Non-English speaking
- Definite developmental delay
Where in United States
- Cincinnati Childrens Hospital Medical CenterCincinnati, United States
About the trial
What the trial wants to find out
This will be a prospective observational study to determine the association between specific genotypes, epigenetics, behavioral, social and biological factors, with the phenotypes, defined by pain perception, postoperative pain, analgesic effects, side effects to perioperative analgesics, chronic postoperative pain, and gene expression in patients following pectus excavatum repair.
The 2 groups in the trial
- ControlNo study treatment, for comparison
Participants in the control group will receive present standard of care, which includes an assessment of participant/family needs by integrative care after surgery, as well as standard holistic health care by a licensed/certified holistic health specialist. They will not receive the MUSETM focused-attention meditation training or intervention protocol.
- MeditationTreatment being tested
Participants randomized to receive focused-attention meditation training will attend a preoperative training session, provided by a licensed/certified Holistic Health Specialist. The content will include an age appropriate explanation of focused-attention meditation, using breath as the focus; set-up and utilization of the MUSETM headband; and experiential practices. The goal of the intervention is to increase mindfulness (i.e., moment-to-moment, non-judgmental and non-reactive awareness of sensations, emotions, and thoughts), provide self-regulation strategies, and promote healthy and adaptive responses to stress.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Genetic, Epigenetic, Psychosocial, and Biological Determinants of Post-surgical Pain After Pectus or Spine Surgery
- Record updated
- 8 October 2026